ArticleFrontiers in pharmacology2026

Therapeutic potential of the Nrf2 activator omaveloxolone in spinocerebellar ataxia type 3 in cellular and

Shin-Hung Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.